$189.99
You save (%)
A targeted cell-penetrating senolytic peptide designed to disrupt the FOXO4-p53 interaction and selectively induce apoptosis in senescent cells for cellular rejuvenation research.
• Purity: 99.70% (HPLC Verified)
• Testing: Independent 3rd-Party Lab Tested
• Documentation: View Certificate of Analysis (COA)
Notice: Strictly for laboratory research and development use only. Not for human or animal consumption.
Availability: In stock
Research Context:
A targeted senolytic peptide studied for its ability to selectively induce apoptosis in senescent cells, widely investigated for its potential role in cellular rejuvenation, healthy aging, and tissue function research.
Quality & Testing:
Purity: 99.70%
(Verified via HPLC)
Testing Status: Independent Third-Party Tested
Reviews
There are no reviews yet.